ZymoGentics Incorporated Company Profile

08:16 EST 24th November 2017 | BioPortfolio

We have had a continuous 20-year focus on the discovery and development of therapeutic proteins. In our early years, we utilized a "biology-first" approach where we evaluated the biology of a disease process and determined the proteins involved. More recently, we have taken a bioinformatics-driven "gene-first" discovery approach where we explore sequence databases in search of novel gene sequences that have properties suggestive of potential therapeutic utility. This gene-first approach requires the subsequent identification of biological activities associated with the newly discovered gene and the determination of potential therapeutic utility for the corresponding protein.

While a bioinformatics-driven strategy is still a relatively new approach for the development of human therapeutics, we believe that our discoveries to date demonstrate the value of this approach in our search for the drugs of tomorrow.


1201 Eastlake Avenue East
United States of America


Phone: 206 4426600
Fax: 206.442.6608

News Articles [1 Associated News Articles listed on BioPortfolio]

Vical Incorporated Announces Pricing of $25 Million Underwritten Public Offering of Common Stock

SAN DIEGO, Nov. 08, 2017 (GLOBE NEWSWIRE) -- Vical Incorporated (Nasdaq:VICL) today announced the pricing of its underwritten public offering of 14,285,714 shares of common stock or common stock ...

PubMed Articles [0 Results]


Clinical Trials [0 Results]


Companies [37 Associated Companies listed on BioPortfolio]


PRAECIS PHARMACEUTICALS INCORPORATED is a biopharmaceutical company focused on the discovery and development of novel compounds to address unmet medical needs or improve existing therapies.PRAECIS has...

ZymoGentics Incorporated

We have had a continuous 20-year focus on the discovery and development of therapeutic proteins. In our early years, we utilized a "biology-first" approach where we evaluated the biology of a disease ...


Founded in 2008 by the Axis Biotec Brasil™ group (, PharmaPraxis has incorporated technologies, and will develop and launch biologic products in Brazil....


COOK SIS is sold under various brand names to treat a wide range of conditions including management of dermal wounds and burns, reinforcement of many types of weakened tissue, and treatment of urinary...

LCG Systems

Founded by Conrad Kenley in 1990, LCG, Inc. is a leader in providing grants management solutions to health and social services agencies. LCG Systems (a subsidiary of LCG, Inc.) ...

More Information about "ZymoGentics Incorporated" on BioPortfolio

We have published hundreds of ZymoGentics Incorporated news stories on BioPortfolio along with dozens of ZymoGentics Incorporated Clinical Trials and PubMed Articles about ZymoGentics Incorporated for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of ZymoGentics Incorporated Companies in our database. You can also find out about relevant ZymoGentics Incorporated Drugs and Medications on this site too.

Quick Search

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Bioinformatics is the application of computer software and hardware to the management of biological data to create useful information. Computers are used to gather, store, analyze and integrate biological and genetic information which can then be applied...

Biological Therapy
Biological therapy involves the use of living organisms, substances derived from living organisms, or laboratory-produced versions of such substances to treat disease. Some biological therapies for cancer use vaccines or bacteria to stimulate the body&rs...

Corporate Database Quicklinks

Searches Linking to this Company Record